CID is 36314
synonyms found at PubChem are:
paclitaxel, TAXOL, 33069-62-4, Taxol A, Abraxane, Paxene, Paxceed, Plaxicel, Yewtaxan, Onxol, Ebetaxel, Capxol, Genaxol, nab-paclitaxel, LipoPac, ABI-007, Paclitaxel (Taxol), Cyclopax, Genetaxyl, Genexol, Intaxel, Mitotax, Padexol, TaxAlbin, Zisu, OncoGel, EmPAC, Xorane, NSC-125973, ABI 007, UNII-P88XT4IS4D, NSC125973, BMS 181339-01, HSDB 6839, DRG-0190, MBT 0206, QW 8184, P88XT4IS4D, BMS-181339-01, CHEMBL428647, CHEBI:45863, 7-epi-Paclitaxel, NSC 125973, 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine, NCGC00164367-01, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, Anzatax, Cynviloq, Nanoxel, Pacliex, Sindaxel, Cypher select, Coroflex Please, Taxus stent, Taxus Express, Taxus Liberte, (NAB)-Paclitaxel, SMR000857385, EndoTAG 1, EndoTAG-1, LEP-ETU, SR-01000075350, Abraxane I.V. Suspension, nabpaclitaxel, Infinnium, Nanotaxel, Paclical, Pacligel, Paxoral, Onxal, Paclitaxel/, CCRIS 8143, Vascular Wrap, Genexol-PM, DHP 107, Paclitaxel,(S), Tocosol Paclitaxel, Paclitaxel [USAN:USP:INN:BAN], Abraxane (TN), (2alpha,5beta,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl benzoate, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate, 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine, [diacetoxy-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-dihydroxy-tetramethyl-oxo-[?]yl] benzoate, Nanoparticle albumin bound paclitaxel, CAS-33069-62-4, IG 001, NK 105, BMS-181339, Paclitaxel-SSMM-VIP, Liposome-entrapped paclitaxel easy-to-use, P-SSMM-VIP, AC1L1VJI, Prestwick3_000155, DSSTox_CID_3413, TAXOL (TN), SCHEMBL3976, DSSTox_RID_77016, Nova-12005, BIDD:PXR0046, DSSTox_GSID_23413, BSPBio_000290, KBioGR_002509, KBioSS_002517, Paclitaxel (JAN/USP/INN), MLS002154218, MLS002695976, OAS-PAC-100, BPBio1_000320, GTPL2770, MEGxp0_001940, Taxol (TN) (Bristol Meyers), DTXSID9023413, ACon1_002231, KBio2_002509, KBio2_005077, KBio2_007645, KBio3_002987, ANX-513, DHP-107, DHP-208, DTS-301, SDP-013, 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv., cMAP_000068, MolPort-001-742-627, RCINICONZNJXQF-MZXODVADSA-N, ZX-AFC000078, HMS2090D07, HMS2095O12, HMS2231A16, HMS3712O12, Abraxane (albumin-bound suspension), ACT02709, Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alpha-R*,beta-S*),11-alpha,12-alpha,12a-alpha, 12b-alpha))-, Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-, HY-B0015, MPI-5018, Tox21_112107, ABP000252, BDBM50001839, MFCD00869953, NSC745099, ZINC96006020, AKOS007930675, AKOS015969673, AKOS025312303, ACN-032459, CCG-220155, CS-1145, DB01229, GS-6554, NSC-745099, RL03195, NCGC00164367-02, NCGC00164367-03, NCGC00164367-04, NCGC00164367-05, NCGC00164367-10, Paclitaxel, From Taxus brevifolia, 95%, AK108391, NA090030, NCI60_000601, SY016928, Paclitaxel, from Taxus yannanensis, powder, AB0069184, ST2419771, AB00513812, N1361, D00491, M-8858, N88686, 10337-EP2269989A1, 10337-EP2270018A1, 10337-EP2272827A1, 10337-EP2272832A1, 10337-EP2277507A1, 10337-EP2277865A1, 10337-EP2277876A1, 10337-EP2280012A2, 10337-EP2280014A2, 10337-EP2281815A1, 10337-EP2281820A2, 10337-EP2286795A1, 10337-EP2287168A2, 10337-EP2289876A1, 10337-EP2289892A1, 10337-EP2292233A2, 10337-EP2292234A1, 10337-EP2292614A1, 10337-EP2292615A1, 10337-EP2295412A1, 10337-EP2295413A1, 10337-EP2295416A2, 10337-EP2298748A2, 10337-EP2298754A1, 10337-EP2298772A1, 10337-EP2298780A1, 10337-EP2301533A1, 10337-EP2301536A1, 10337-EP2301538A1, 10337-EP2301928A1, 10337-EP2301933A1, 10337-EP2301940A1, 10337-EP2302382A2, 10337-EP2302383A2, 10337-EP2305243A1, 10337-EP2305250A1, 10337-EP2305640A2, 10337-EP2305642A2, 10337-EP2305671A1, 10337-EP2305679A1, 10337-EP2305689A1, 10337-EP2305808A1, 10337-EP2308833A2, 10337-EP2308839A1, 10337-EP2308861A1, 10337-EP2311455A1, 10337-EP2311808A1, 10337-EP2311827A1, 10337-EP2311829A1, 10337-EP2314295A1, 10337-EP2314574A1, 10337-EP2316452A1, 10337-EP2316832A1, 10337-EP2316833A1, AB00513812-02, AB00513812-03, 069P624, Paclitaxel, Antibiotic for Culture Media Use Only, 7,4]benz[1,2-b]oxete,benzenepropanoic acid deriv., Q-201533, SR-01000075350-1, SR-01000075350-3, SR-01000075350-6, SR-01000075350-7, SR-01000075350-9, BRD-K62008436-001-03-1, BRD-K62008436-001-05-6, BRD-K62008436-001-22-1, Paclitaxel, from semisynthetic (from Taxus sp.), >=97%, Paclitaxel, European Pharmacopoeia (EP) Reference Standard, Paclitaxel, from Taxus brevifolia, >=95% (HPLC), powder, Paclitaxel, United States Pharmacopeia (USP) Reference Standard, 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine, Paclitaxel, Pharmaceutical Secondary Standard; Certified Reference Material, 7,11-METHANO-5H-CYCLODECA[3,4]BENZ[1,2-B]OXETE BENZENEPROPANOIC ACID DERIV., Paclitaxel natural for peak identification, European Pharmacopoeia (EP) Reference Standard, (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0;{3,10}.0;{4,7}]heptadec-13-en-2-yl benzoate, (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro 4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano 5Hcyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate,, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-(benzoylamino)-a-hydroxybenzenepropanoate, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12, 1203669-79-7, 157069-30-2, 4alpha,10beta-bis(acetyloxy)-13alpha-[(2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyloxy]-1,7beta-dihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate, 5?,20-Epoxy-1,7?-dihydroxy-9-oxotax-11-ene-2?,4,10?,13?-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate], Benzenepropanoic acid, 6,12b-bis(acetyl oxy)-12-(benzoyloxy)- 2a,3,4,4a,5,6,9,10,11,12,12a,12b,- dodecahydro-4,11- dihydroxy-4a,8,13,13-tetramethyl-5-oxo- 7,11-methano- 1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR- [2a.alpha.,4.beta.,4a.beta.,6.beta.,9.alpha.(alpha. R*,.beta.S*),11.alpha.,12.alpha.,12a.alpha.,12b.alpha.]]-, Benzenepropanoic acid, b-(benzoylamino)-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (aR,bS)-, Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13, Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-, Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H, Paclitaxel semi-synthetic for peak identification, European Pharmacopoeia (EP) Reference Standard, Paclitaxel semi-synthetic for system suitability, European Pharmacopoeia (EP) Reference Standard, Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha- hexahydroxy-, 4,10-diacetate 2-benzoate, 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI), Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxy-, 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI), Tax-11-en-9-one,20-epoxy-1,2.alpha.,4,7.beta., 10.beta.,13.alpha.- hexahydroxy-, 4,10-diacetate 2- benzoate,13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine